111, Inc.YI

NasdaqConsumer EssentialsRetail-Drug Stores and Proprietary Stores
Price (close)
$3.59
Market cap
—
P/E
—
Revenue (FY)
$12.6B
Net income
-$18.4M
Dividend yield
—
1-year total return
-25.5%
Net margin
-0.1%
Revenue growth
-12.8%
Debt / equity
—

What 111, Inc. does.

In 2010, our founders launched 1 Medicine Marketplace (1 药网 ), one of the first online retail pharmacies in China. Today, we provide hundreds of millions of consumers with better access to pharmaceutical products and medical services, directly through our online retail pharmacy network. Our online wholesale pharmacy, 1 Pharmacy (1 药城 ), serves as a one-stop shop for pharmacies, clinics and hospitals, among others, to source a vast selection of pharmaceutical products.

We aim to create a leading digital healthcare platform in China, with a mission to connect patients with medicine and healthcare services digitally. The platform offers a wide range of healthcare services, including consultations, diagnosis, delivery of medication, tools to enable both upstream pharmaceutical manufacturers and downstream pharmacies. Consumers can access these services through the digital platform, enabling them to receive medical advice and consultation services from their homes. Businesses can leapfrog the traditional ways of conducting business and can access a range of services digitally, with much greater efficiency. This digital platform has made healthcare services more accessible, convenient, and affordable for individuals and businesses with great user experience.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$8.2B$12.4B$13.5B$14.9B$14.4B$12.6B
Net income-$467.1M-$593.2M-$360.8M-$336.6M-$12.4M-$18.4M
Free cash flow-$142.3M-$751.4M-$54.7M-$457.1M$247.8M$114.7M

More on YI.

Figures from 111, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.